Despite the three biomarkers displaying significantly altered levels in specific subsets of MD patients, we did not find statistical correlation between pGSN, FGF-21, and GDF-15 concentrations neither in our MD patient cohort, nor in any of the MD subgroups. This evidence concerns the gene FGF21 and Menkes disease.